ex4-4 -- Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing







    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    
















    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    





Table 1 To


Purchase Agreement No. PA-03600


Aircraft Delivery, Description, Price
and Advance Payments


 


 


	Airframe
        Model/MTOW: 


 

        
	777-Freighter	766800
    Pounds	
	Detail
    Specification:	D019W007-D
        (2/19/2010)

        
	 
	Engine
        Model/Thrust: 


 
	GE90-110BIL	110100
    Pounds	 	Airframe
    Price Base Year/Escalation Formula:	***	***
	Airframe
        Price:  


 
	***	 	Engine
    Price Base Year/Escalation Formula:	N/A	N/A
	Optional
        Features:  


 
	***	 	 	 	 
	Sub-Total
        of Airframe and Features:  


 
	***	 	Airframe
    Escalation Data:	 	 
	Engine
        Price (Per Aircraft):  


 
	***	 	Base
    Year Index(ECI):	***	 
	Aircraft
        Basic Price (Excluding BFE/SPE):  


 
	***	 	Base
    Year Index(ICI):	***	 
	Buyer
        Furnished Equipment (BFE) Estimate: 


 
	***	 	 	 	 
	Seller
        Purchased Equipment (SPE) Estimate: 
	***	 	 	 	 


 





Deposit per
Aircraft: 


 


	
        Delivery

        Date

         
	
        Number of

        Aircraft

         
	
        Escalation

        Factor

        (Airframe)
	 	 	***	
        ***

         

	 	***	***	***	***
	Jul-2013	1	***	 	 	***	***	***	***	***
	Aug-2013	1	***	 	 	***	***	***	***	***
	Jul-2014	1	***	 	 	***	***	***	***	***
	Aug-2014	1	***	 	 	***	***	***	***	***
	Jun-2015	1	***	 	 	***	***	***	***	***
	Jul-2015	1	***	 	 	***	***	***	***	***
	Total:	6	 	 	 	 	 	 	 	 


 


 





	 GUN-PA-03600 56603-1F.TXT	Boeing Proprietary 	Page 1



 







    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    


    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    
















    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    











    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    











*** Following 3 Pages Omitted
    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    



    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    


















    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









 
    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    











    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    









*** Following 11 Pages Omitted 
    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    












    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.



    	 



    



    	*** This information is subject to confidential treatment and has been omitted and filed separately with the Commission.